Heart mapping procedure could unlock better genetic answers for rare disease
NCT ID NCT03177018
Summary
This study tested whether doctors could collect heart muscle cells during a standard heart mapping procedure and use their DNA to improve genetic testing for a rare heart condition called arrhythmogenic right ventricular cardiomyopathy (ARVC). Researchers worked with 34 patients who already needed the mapping procedure for their ARVC diagnosis. The goal was to see if this cell collection method could provide clearer genetic information than standard blood tests, which sometimes miss the cause of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cardiology-rytmology service
Paris, France
-
University Hospital Toulouse - Cardiology Department
Toulouse, 31000, France
Conditions
Explore the condition pages connected to this study.